Richard J Mckittrick, MD - Medicare Medical Oncology in Overland Park, KS

Richard J Mckittrick, MD is a medicare enrolled "Internal Medicine - Hematology & Oncology" physician in Overland Park, Kansas. He went to University Of Kansas School Of Med (kc/wich/sal) and graduated in 1986 and has 38 years of diverse experience with area of expertise as Medical Oncology. He is a member of the group practice University Of Kansas Hospital Authority, University Of Kansas Hospital Authority and his current practice location is 12200 W 110th St, Overland Park, Kansas. You can reach out to his office (for appointments etc.) via phone at (913) 574-2650.

Richard J Mckittrick is licensed to practice in Kansas (license number 0423158) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1932170537.

Contact Information

Richard J Mckittrick, MD
12200 W 110th St,
Overland Park, KS 66210-4045
(913) 574-2650
(913) 574-2769



Physician's Profile

Full NameRichard J Mckittrick
GenderMale
SpecialityMedical Oncology
Experience38 Years
Location12200 W 110th St, Overland Park, Kansas
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Richard J Mckittrick attended and graduated from University Of Kansas School Of Med (kc/wich/sal) in 1986
  NPI Data:
  • NPI Number: 1932170537
  • Provider Enumeration Date: 01/31/2006
  • Last Update Date: 08/24/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 4981654233
  • Enrollment ID: I20050125000822

Medical Identifiers

Medical identifiers for Richard J Mckittrick such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1932170537NPI-NPPES
100126220CMedicaidKS
1932170537MedicaidMO
100126220DMedicaidKS

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RH0003XInternal Medicine - Hematology & Oncology 108885 (Missouri)Secondary
207RH0003XInternal Medicine - Hematology & Oncology 0423158 (Kansas)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
University Of Kansas HospitalKansas city, KSHospital
St Joseph Medical CenterKansas city, MOHospital
Lawrence Memorial HospitalLawrence, KSHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
University Of Kansas Hospital Authority9436054798250
University Of Kansas Hospital Authority9436054798250

News Archive

FDA grants orphan-drug designation to Convergence's CNV1014802 for treatment of TN

Convergence Pharmaceuticals Limited, the company focused on the development of novel and high value analgesic medicines for the treatment of chronic pain, is pleased to announce that its novel sodium channel blocker, CNV1014802 ('802), has been granted orphan-drug designation by the US Food and Drug Administration for the treatment of trigeminal neuralgia.

New gene editing technique could hinder retinal degeneration in rats with inherited blindness

A new technique that has the potential to treat inherited diseases by removing genetic defects has been shown for the first time to hinder retinal degeneration in rats with a type of inherited blindness, according to a Cedars-Sinai study.

Policymakers, insurers should consider generic-only coverage to improve health and reduce costs

A new study published online today in the American Journal of Managed Care found that in Medicare Part D, generic drug coverage was cost-saving compared to no coverage in bipolar disorder and schizophrenia, while also improving health outcomes.

NOVAVAX completes patient enrollment in its trivalent seasonal influenza VLP vaccine Phase II study

Novavax, Inc. announced today it has completed enrollment in the Phase II clinical study of its trivalent seasonal influenza (2008/2009 recommended strains) VLP vaccine candidate in healthy adults 60 years of age or older (older adults). This randomized, double-blind, active-controlled study is comparing the safety, tolerability and immunogenicity of two different doses (15 mcg and 60 mcg) of Novavax's trivalent seasonal influenza VLP vaccine to a commercially available trivalent inactivated vaccine, TIV (FluzoneĀ®).

Clinical value of OrSense NBM 200 non-invasive Hb monitor for maternal health to be presented at 4th COGI

OrSense Ltd., announced today that two oral presentations on the clinical value of its NBM 200 non-invasive hemoglobin (Hb) monitor for maternal health and anemia monitoring prior, during and post delivery of pregnant women will be presented at the 4th Asia Pacific Congress on Controversies in Obstetrics Gynecology and Infertility (COGI).

Read more Medical News

› Verified 9 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Richard J Mckittrick allows following entities to bill medicare on his behalf.
Entity NameUniversity Of Kansas Hospital Authority
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1528019502
PECOS PAC ID: 9436054798
Enrollment ID: O20110607000604

News Archive

FDA grants orphan-drug designation to Convergence's CNV1014802 for treatment of TN

Convergence Pharmaceuticals Limited, the company focused on the development of novel and high value analgesic medicines for the treatment of chronic pain, is pleased to announce that its novel sodium channel blocker, CNV1014802 ('802), has been granted orphan-drug designation by the US Food and Drug Administration for the treatment of trigeminal neuralgia.

New gene editing technique could hinder retinal degeneration in rats with inherited blindness

A new technique that has the potential to treat inherited diseases by removing genetic defects has been shown for the first time to hinder retinal degeneration in rats with a type of inherited blindness, according to a Cedars-Sinai study.

Policymakers, insurers should consider generic-only coverage to improve health and reduce costs

A new study published online today in the American Journal of Managed Care found that in Medicare Part D, generic drug coverage was cost-saving compared to no coverage in bipolar disorder and schizophrenia, while also improving health outcomes.

NOVAVAX completes patient enrollment in its trivalent seasonal influenza VLP vaccine Phase II study

Novavax, Inc. announced today it has completed enrollment in the Phase II clinical study of its trivalent seasonal influenza (2008/2009 recommended strains) VLP vaccine candidate in healthy adults 60 years of age or older (older adults). This randomized, double-blind, active-controlled study is comparing the safety, tolerability and immunogenicity of two different doses (15 mcg and 60 mcg) of Novavax's trivalent seasonal influenza VLP vaccine to a commercially available trivalent inactivated vaccine, TIV (FluzoneĀ®).

Clinical value of OrSense NBM 200 non-invasive Hb monitor for maternal health to be presented at 4th COGI

OrSense Ltd., announced today that two oral presentations on the clinical value of its NBM 200 non-invasive hemoglobin (Hb) monitor for maternal health and anemia monitoring prior, during and post delivery of pregnant women will be presented at the 4th Asia Pacific Congress on Controversies in Obstetrics Gynecology and Infertility (COGI).

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Richard J Mckittrick is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Richard J Mckittrick, MD
11300 Corporate Ave,
Lenexa, KS 66219-1374

Ph: (913) 574-2650
Richard J Mckittrick, MD
12200 W 110th St,
Overland Park, KS 66210-4045

Ph: (913) 574-2650

News Archive

FDA grants orphan-drug designation to Convergence's CNV1014802 for treatment of TN

Convergence Pharmaceuticals Limited, the company focused on the development of novel and high value analgesic medicines for the treatment of chronic pain, is pleased to announce that its novel sodium channel blocker, CNV1014802 ('802), has been granted orphan-drug designation by the US Food and Drug Administration for the treatment of trigeminal neuralgia.

New gene editing technique could hinder retinal degeneration in rats with inherited blindness

A new technique that has the potential to treat inherited diseases by removing genetic defects has been shown for the first time to hinder retinal degeneration in rats with a type of inherited blindness, according to a Cedars-Sinai study.

Policymakers, insurers should consider generic-only coverage to improve health and reduce costs

A new study published online today in the American Journal of Managed Care found that in Medicare Part D, generic drug coverage was cost-saving compared to no coverage in bipolar disorder and schizophrenia, while also improving health outcomes.

NOVAVAX completes patient enrollment in its trivalent seasonal influenza VLP vaccine Phase II study

Novavax, Inc. announced today it has completed enrollment in the Phase II clinical study of its trivalent seasonal influenza (2008/2009 recommended strains) VLP vaccine candidate in healthy adults 60 years of age or older (older adults). This randomized, double-blind, active-controlled study is comparing the safety, tolerability and immunogenicity of two different doses (15 mcg and 60 mcg) of Novavax's trivalent seasonal influenza VLP vaccine to a commercially available trivalent inactivated vaccine, TIV (FluzoneĀ®).

Clinical value of OrSense NBM 200 non-invasive Hb monitor for maternal health to be presented at 4th COGI

OrSense Ltd., announced today that two oral presentations on the clinical value of its NBM 200 non-invasive hemoglobin (Hb) monitor for maternal health and anemia monitoring prior, during and post delivery of pregnant women will be presented at the 4th Asia Pacific Congress on Controversies in Obstetrics Gynecology and Infertility (COGI).

Read more News

› Verified 9 days ago


Internal Medicine Doctors in Overland Park, KS

Dr. Matthew P Harrison, MD
Hematology & Oncology
Medicare: Medicare Enrolled
Practice Location: 10116 W 105th St, Overland Park, KS 66212
Phone: 913-541-0510    Fax: 913-541-1852
Louay K. Sabih, M.D.
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 10550 Marty St Ste 201, Overland Park, KS 66212
Phone: 913-341-4000    Fax: 913-383-2868
Kimberly Foley Nagel, ARNP
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 5701 W 119th St, Suite 345, Overland Park, KS 66209
Phone: 913-339-9046    Fax: 913-339-9018
Dr. Paul G Diederich, M.D.
Hematology & Oncology
Medicare: Not Enrolled in Medicare
Practice Location: 10787 Nall Ave, Ste. 310, Overland Park, KS 66211
Phone: 913-945-6900    Fax: 913-945-6970
Mini R Abraham, M.D.
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 10000 College Blvd, Overland Park, KS 66210
Phone: 913-258-5055    Fax: 913-258-5057
Jeena Viji Eapen, M.D.
Hematology & Oncology
Medicare: May Accept Medicare Assignments
Practice Location: 10540 Marty St Ste 100, Overland Park, KS 66212
Phone: 913-660-1616    Fax: 913-660-0998
Dr. Arnold Leslie Katz, MD
Hematology & Oncology
Medicare: May Accept Medicare Assignments
Practice Location: 10550 Quivira Road, Suite 320, Overland Park, KS 66215
Phone: 913-888-3231    Fax: 913-888-7281

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.